| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Mr. Michael A. MarksCFO & Exec. VP | -3.34k | 0.00 | Other Disposition | - | 73.08k | -4.37% |
| 2026-02-13 | Mr. Michael R. McAleveyExec. VP and Chief Legal & Administrative Officer | -5.00k | 1.51M | Derivative Exercise and Sale | 236.61 - 540.29 | 10.99k | - |
| 2026-02-11 | Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller | -4.00k | 2.02M | 売り | 505.00 | 44.38k | -8.27% |
| 2026-02-10 | Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller | -1.03k | 519.12k | Sale to Issuer | 502.05 | 44.38k | -2.28% |
| 2026-02-10 | Ms. Erica L. RossittoSenior VP & Chief Nurse Executive | -418.00 | 209.86k | Sale to Issuer | 502.05 | 10.41k | -3.86% |
| 2026-02-10 | Mr. Michael R. McAleveyExec. VP and Chief Legal & Administrative Officer | -3.01k | 1.51M | Sale to Issuer | 502.05 | 10.99k | -21.48% |
| 2026-02-10 | Mr. Michael A. MarksCFO & Exec. VP | -1.69k | 848.46k | Sale to Issuer | 502.05 | 73.08k | -2.26% |
| 2026-02-10 | Mr. Samuel N. HazenCEO & Director | -21.32k | 10.71M | Sale to Issuer | 502.05 | 1.38M | -1.52% |
| 2026-02-10 | Mr. Jon Mack FosterExec. VP & COO | -5.89k | 2.96M | Sale to Issuer | 502.05 | 194.52k | -2.94% |
| 2026-02-10 | Dr. Michael S. CuffeExec. VP & Chief Clinical Officer | -3.50k | 1.76M | Sale to Issuer | 502.05 | 32.08k | -9.84% |
| 2026-02-11 | Ms. Jennifer L. BerresSenior VP & Chief HR Officer | -8.02k | 4.13M | 売り | 503.00 - 526.16 | 11.99k | -40.07% |
| 2026-02-10 | Ms. Jennifer L. BerresSenior VP & Chief HR Officer | -2.52k | 1.26M | Sale to Issuer | 502.05 | 11.99k | -17.34% |
| 2026-02-06 | Hercules Holding Ii, LLC法人 | -36.63M | 0.00 | Other Disposition | - | 32.28M | -53.15% |
| 2026-02-06 | Frisco Holding II法人 | -36.63M | 0.00 | Other Disposition | - | - | - |
| 2026-02-05 | Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller | 5.00k | 694.74k | Derivative Exercise and Retained Stock | 139.06 | 46.06k | 12.17% |
| 2026-02-05 | Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller | -5.67k | 2.13M | Derivative Exercise and Sale | 139.06 - 513.76 | 46.06k | - |
| 2026-02-05 | Mr. Jon Mack FosterExec. VP & COO | 13.25k | 1.84M | Derivative Exercise and Retained Stock | 139.06 | 184.71k | 7.73% |
| 2026-02-05 | Mr. Jon Mack FosterExec. VP & COO | -16.08k | 6.02M | Derivative Exercise and Sale | 139.06 - 513.76 | 184.71k | - |
| 2026-02-03 | Mr. Samuel N. HazenCEO & Director | -42.88k | 21.48M | 売り | 497.18 - 502.95 | 1.35M | -3.08% |
| 2026-02-04 | Mr. Samuel N. HazenCEO & Director | -1.05k | 520.78k | Other Disposition | 498.35 | 1.35M | -0.08% |
| 2026-02-03 | Dr. Michael S. CuffeExec. VP & Chief Clinical Officer | -1.50k | 747.14k | 売り | 498.09 | 25.95k | -5.46% |
| 2026-02-03 | Dr. Michael S. CuffeExec. VP & Chief Clinical Officer | -4.05k | 0.00 | Other Disposition | - | 25.95k | -13.50% |
| 2026-01-30 | Mr. Samuel N. HazenCEO & Director | 42.88k | 3.51M | Derivative Exercise and Retained Stock | 81.96 | 1.39M | 3.18% |
| 2026-01-30 | Mr. Samuel N. HazenCEO & Director | -41.48k | 16.85M | Derivative Exercise and Sale | 81.96 - 488.27 | 1.39M | - |
| 2025-11-14 | Mr. Samuel N. HazenCEO & Director | -14.83k | 0.00 | Other Disposition | - | 1.35M | -1.09% |
| 2025-11-03 | Mr. Michael R. McAleveyExec. VP and Chief Legal & Administrative Officer | -13.17k | 3.01M | Derivative Exercise and Sale | 236.61 - 473.79 | 5.62k | - |
| 2025-11-03 | Mr. Michael A. MarksCFO & Exec. VP | -330.00 | 0.00 | Other Disposition | - | 69.74k | -0.47% |
| 2025-10-31 | Mr. Samuel N. HazenCEO & Director | 29.88k | 2.08M | Derivative Exercise and Retained Stock | 69.58 | 1.36M | 2.24% |
| 2025-10-31 | Mr. Samuel N. HazenCEO & Director | -28.17k | 10.99M | Derivative Exercise and Sale | 69.58 - 459.68 | 1.36M | - |
| 2025-09-04 | Dr. Michael S. CuffeExec. VP & Chief Clinical Officer | -10.92k | 2.63M | Derivative Exercise and Sale | 173.12 - 418.84 | 31.50k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。